In conclusion, miR-8485-mediated downregulation of UBN2, ETS1, MMS22L, GSK3B, and SLC44A1 inhibits tumor progression through mechanisms involving cell cycle arrest, metastasis inhibition, apoptosis induction, and choline metabolism. Here, UBN2 is linked to neoplasm.